Patients with nonvalvular atrial fibrillation (NAVF) who also have diabetes experienced similar safety and efficacy with dabigatran relative to warfarin, in comparison without diabetes who have NVAF.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.